ARVNArvinas, Inc.
$7.52-19% 1Y
$7.52
$6.9852 weeks$13.83
The financials
Arvinas, Inc. by the numbers
Arvinas, Inc. (ARVN) reported revenue of $250M in Q2 2026 (quarter ended Jun 30, 2026), up 1015% from the same quarter a year earlier. That came with net income of $169M (68% of revenue). For the full year FY2025, revenue was $263M (−0.3% year on year) and net income −$81M. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $250M | $22M | +1015% |
| Operating income | $164M | −$72M | to a profit |
| Net income | $169M | −$61M | to a profit |
| Diluted EPS | $2.58 | −$0.84 | to a profit |
Biotechnology
The closest names by size in the same industry